SARSCoV2

Susceptibility of Circulating Variants of SARS-CoV-2 for Neutralization

Comparative study of SARS, MERS, BAT-SARS and SARS-CoV-2

New variants of SARS-CoV-2 – clinical, public health and vaccine implications

Individual immunity from SARS-CoV-2 neutralizing antibodies lasts from days to decades

SARS-CoV-2 infection after vaccination in healthcare professionals in California

Scientists may have discovered how SARS-CoV-2 passed from animals to humans

The FDA allows the commercialization of the first SARS-CoV-2 diagnostic test using the traditional pre-marketing review process

Increased mortality in cases tested by the SARS-CoV-2 lineage community B.1.1.7

The cannabis compound inhibits the replication of SARS-CoV-2 in human lung cells

Vaccine-induced antibodies may be less effective against several new variants of SARS-CoV-2: study

SARS-CoV-2 jumped from bats to humans without much change

Immunity to worrying SARS-CoV-2 variants